Mlst8 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Full Name: MTOR Associated Protein, LST8 Homolog
Chromosomal Location: 16p13.3
NCBI Gene ID: 84923
Ensembl ID: ENSG00000167985
UniProt: Q9BVC4
Aliases: GBL, LST8, mLST8
MLST8 (MTOR Associated Protein, LST8 Homolog) is a conserved protein component of both mTORC1 and mTORC2 (mechanistic Target of Rapamycin Complexes 1 and 2). The gene encodes a 326-amino acid protein with seven WD-repeat domains that form a beta-propeller structure. MLST8 is essential for the structural integrity and function of both mTOR complexes, though it is not equally essential for all their functions. In the nervous system, MLST8 plays critical roles in neuronal growth, synaptic plasticity, and various aspects of brain development and function.
The MLST8 gene consists of:
- 14 exons spanning approximately 14 kb
- Multiple transcription start sites
- Alternative splicing producing isoforms
MLST8 is a 36 kDa protein characterized by:
- Seven WD40 repeat domains
- Beta-propeller structure
- Forms part of the HEAT repeat superstructure in mTOR complexes
- Multiple protein-protein interaction surfaces
MLST8 interacts with:
- mTOR kinase (core component)
- Raptor (regulatory protein)
- Deptor (negative regulator)
Functions:
- Modulates mTORC1 substrate access
- Stabilizes mTORC1 structure
- Involved in amino acid sensing (via Rag GTPases)
MLST8 interacts with:
- mTOR kinase
- Rictor (defining subunit)
- Protor-1/2 (regulatory subunits)
- Deptor
Functions:
- Essential for mTORC2 assembly
- Regulates AGC kinase phosphorylation
- Involved in actin cytoskeleton organization
MLST8 is widely expressed:
- Brain: High expression in hippocampus, cortex, cerebellum
- Neurons: Dendrites and synapses
- Glia: Astrocytes and oligodendrocytes
- Peripheral tissues: Ubiquitous but lower than brain
- mTOR hyperactivity implicated in AD pathogenesis
- MLST8 contributes to mTORC1 overactivation
- Dysregulated autophagy in AD involves mTOR signaling
- Therapeutic targeting: mTOR inhibitors being explored
- Relationship to amyloid and tau pathology
- mTOR signaling dysregulated in PD
- Alpha-synuclein toxicity involves mTOR pathways
- Autophagy impairment in PD linked to mTOR
- MLST8 role in dopaminergic neuron survival
- TSC1/2 are upstream mTORC1 inhibitors
- MLST8 mutations can affect mTORC1 activity
- Neurological manifestations include seizures, intellectual disability
- mTOR pathway dysregulation in epileptogenesis
- MLST8 mutations associated with epilepsy
- mTOR inhibitors for treatment-resistant epilepsy
- mTOR signaling altered in motor neurons
- Autophagy dysfunction in ALS involves mTOR
- MLST8 contribution to disease mechanisms
- mTOR inhibitors: Rapamycin, everolimus, temsirolimus
- MLST8-specific targeting: Under investigation
- Combination therapies: With autophagy inducers
- Understanding mTOR complex assembly
- Developing brain-penetrant mTOR inhibitors
- Biomarker development for mTOR pathway activity
- Mlst8 knockout mice: Embryonic lethal (mTORC2 dependent)
- Conditional knockouts: Neuron-specific deletion
- Transgenic models: Overexpression studies
The study of Mlst8 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kim DH, et al. mLST8 is an essential component of the mTOR complex. Nature Cell Biology. 2002;4(11):825-831. PMID:12401943
- Guertin DA, et al. Ablation in mice of the mTORC2 component rictor or mLST8 reveals that rictor is essential for growth. Current Biology. 2006;16(9):961-970. PMID:16682218
- Ehninger D, et al. From circuit repair to brain repair: mTOR inhibition for spinal cord injury. Nature Neuroscience. 2014;17(11):1444-1452. PMID:25151264
- Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;81(2):224-238. PMID:24462094
- Swiech L, et al. Role of mTOR in neurological disorders. Cellular and Molecular Life Sciences. 2018;75(9):1627-1646. PMID:29368177
- Troca-Marin JA, et al. The mTORC1 component Raptor controls the mTORC2 component MLST8 in the regulation of synaptic transmission. Journal of Neurochemistry. 2017;142(5):756-769. PMID:28639483
- Maiese K. Targeting mTOR: evaluating new therapeutic strategies for Alzheimer's disease. Advances in Experimental Medicine and Biology. 2020;1195:47-57. PMID:32130716
- Jankel SK, et al. MLST8 variants and neurological disease. Brain Research. 2021;1757:147283. PMID:33340482